These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 26174134)

  • 21. Antidepressant and anxiolytic potential of the multimodal antidepressant vortioxetine (Lu AA21004) assessed by behavioural and neurogenesis outcomes in mice.
    Guilloux JP; Mendez-David I; Pehrson A; Guiard BP; Repérant C; Orvoën S; Gardier AM; Hen R; Ebert B; Miller S; Sanchez C; David DJ
    Neuropharmacology; 2013 Oct; 73():147-59. PubMed ID: 23721744
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of acute and sustained administration of vortioxetine on the serotonin system in the hippocampus: electrophysiological studies in the rat brain.
    El Mansari M; Lecours M; Blier P
    Psychopharmacology (Berl); 2015 Jul; 232(13):2343-52. PubMed ID: 25665528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pharmacological properties of vortioxetine and its pre-clinical consequences].
    David DJ; Tritschler L; Guilloux JP; Gardier AM; Sanchez C; Gaillard R
    Encephale; 2016 Feb; 42(1 Suppl 1):1S12-23. PubMed ID: 26879252
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic Vortioxetine Treatment Reduces Exaggerated Expression of Conditioned Fear Memory and Restores Active Coping Behavior in Chronically Stressed Rats.
    Hatherall L; Sánchez C; Morilak DA
    Int J Neuropsychopharmacol; 2017 Apr; 20(4):316-323. PubMed ID: 27927740
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contrasting effects of vortioxetine and paroxetine on pineal gland biochemistry in a tryptophan-depletion model of depression in female rats.
    Franklin M; Hlavacova N; Li Y; Bermudez I; Csanova A; Sanchez C; Jezova D
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Oct; 79(Pt B):499-502. PubMed ID: 28802861
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Translational evaluation of JNJ-18038683, a 5-hydroxytryptamine type 7 receptor antagonist, on rapid eye movement sleep and in major depressive disorder.
    Bonaventure P; Dugovic C; Kramer M; De Boer P; Singh J; Wilson S; Bertelsen K; Di J; Shelton J; Aluisio L; Dvorak L; Fraser I; Lord B; Nepomuceno D; Ahnaou A; Drinkenburg W; Chai W; Dvorak C; Sands S; Carruthers N; Lovenberg TW
    J Pharmacol Exp Ther; 2012 Aug; 342(2):429-40. PubMed ID: 22570363
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vortioxetine, but not escitalopram or duloxetine, reverses memory impairment induced by central 5-HT depletion in rats: evidence for direct 5-HT receptor modulation.
    Jensen JB; du Jardin KG; Song D; Budac D; Smagin G; Sanchez C; Pehrson AL
    Eur Neuropsychopharmacol; 2014 Jan; 24(1):148-59. PubMed ID: 24284262
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vortioxetine restores reversal learning impaired by 5-HT depletion or chronic intermittent cold stress in rats.
    Wallace A; Pehrson AL; Sánchez C; Morilak DA
    Int J Neuropsychopharmacol; 2014 Oct; 17(10):1695-706. PubMed ID: 24852131
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vortioxetine for the treatment of major depressive disorder.
    Tritschler L; Felice D; Colle R; Guilloux JP; Corruble E; Gardier AM; David DJ
    Expert Rev Clin Pharmacol; 2014 Nov; 7(6):731-45. PubMed ID: 25166025
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modeling and Mutational Analysis of the Binding Mode for the Multimodal Antidepressant Drug Vortioxetine to the Human 5-HT
    Ladefoged LK; Munro L; Pedersen AJ; Lummis SCR; Bang-Andersen B; Balle T; Schiøtt B; Kristensen AS
    Mol Pharmacol; 2018 Dec; 94(6):1421-1434. PubMed ID: 30257860
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Translational neurophysiological markers for activity of the metabotropic glutamate receptor (mGluR2) modulator JNJ-40411813: Sleep EEG correlates in rodents and healthy men.
    Ahnaou A; de Boer P; Lavreysen H; Huysmans H; Sinha V; Raeymaekers L; Van De Casteele T; Cid JM; Van Nueten L; Macdonald GJ; Kemp JA; Drinkenburg WH
    Neuropharmacology; 2016 Apr; 103():290-305. PubMed ID: 26686390
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vortioxetine: A review of the pharmacology and clinical profile of the novel antidepressant.
    Sowa-Kućma M; Pańczyszyn-Trzewik P; Misztak P; Jaeschke RR; Sendek K; Styczeń K; Datka W; Koperny M
    Pharmacol Rep; 2017 Aug; 69(4):595-601. PubMed ID: 28499187
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A single dose of vortioxetine, but not ketamine or fluoxetine, increases plasticity-related gene expression in the rat frontal cortex.
    du Jardin KG; Müller HK; Sanchez C; Wegener G; Elfving B
    Eur J Pharmacol; 2016 Sep; 786():29-35. PubMed ID: 27235984
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential interaction with the serotonin system by S-ketamine, vortioxetine, and fluoxetine in a genetic rat model of depression.
    du Jardin KG; Liebenberg N; Müller HK; Elfving B; Sanchez C; Wegener G
    Psychopharmacology (Berl); 2016 Jul; 233(14):2813-25. PubMed ID: 27236785
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vortioxetine in major depressive disorder: from mechanisms of action to clinical studies. An updated review.
    De Diego-Adeliño J; Crespo JM; Mora F; Neyra A; Iborra P; Gutiérrez-Rojas L; Salonia SF
    Expert Opin Drug Saf; 2022 May; 21(5):673-690. PubMed ID: 34964415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Histamine may contribute to vortioxetine's procognitive effects; possibly through an orexigenic mechanism.
    Smagin GN; Song D; Budac DP; Waller JA; Li Y; Pehrson AL; Sánchez C
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jul; 68():25-30. PubMed ID: 26945513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Subchronic vortioxetine treatment -but not escitalopram- enhances pyramidal neuron activity in the rat prefrontal cortex.
    Riga MS; Teruel-Martí V; Sánchez C; Celada P; Artigas F
    Neuropharmacology; 2017 Feb; 113(Pt A):148-155. PubMed ID: 27671324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute effects of vortioxetine and duloxetine on resting-state functional connectivity in the awake rat.
    Pérez PD; Ma Z; Hamilton C; Sánchez C; Mørk A; Pehrson AL; Bundgaard C; Zhang N
    Neuropharmacology; 2018 Jan; 128():379-387. PubMed ID: 29104073
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vortioxetine Subchronically Activates Serotonergic Transmission via Desensitization of Serotonin 5-HT
    Okada M; Okubo R; Fukuyama K
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31835640
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The efficacy of vortioxetine for the treatment of major depressive disorder.
    Dhir A; Sarvaiya J
    Expert Rev Neurother; 2014 Dec; 14(12):1349-63. PubMed ID: 25418918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.